University of Saskatchewan Bonfire #RFP CP-831974

University of Saskatchewan Solicits CRO for PanSarb Vaccine GLP Toxicology Study

The University of Saskatchewan is seeking proposals from qualified Contract Research Organizations (CROs) for a critical vaccine development study: - Government buyer: University of Saskatchewan, Enterprise Procurement office - Service requested: GLP-compliant repeat-dose toxicology study for the PanSarb vaccine - Study supports a Phase 1 (first-in-human) clinical trial application to Health Canada - No specific OEMs or commercial vendors are named in the solicitation - Bidders must provide: - Detailed proposal outlining methodology and experience - Validation documentation - Scope of work - Fee structure - Notable requirements: - Compliance with Good Laboratory Practice (GLP) standards - Ability to support regulatory submission to Health Canada - Opportunity is open to qualified CROs with relevant expertise in vaccine toxicology studies

Description

The University of Saskatchewan is requesting proposals from qualified Contract Research Organizations to conduct a Good Laboratory Practice compliant repeat-dose toxicology study. This study supports a Phase 1 (first-in-human) clinical trial application to Health Canada. The project is currently open for proposals with a deadline for intent to bid on July 3, 2026. Relevant documentation and fee structure sheets are provided for bidders.

View original listing